EQS-Ad-hoc: MAX Automation SE / Key word(s): Disposal DISCLOSURE OF AN INSIDE INFORMATION PURSUANT TO ARTICLE 17 OF THE REGULATION (EU) NO. 596/2014
Hamburg, 8 September 2023 – MAX Automation SE is currently pursuing a structured sales process regarding the MA micro group, consisting of MA micro automation GmbH and its subsidiaries MA Life Science GmbH, Micro Automation LLC, and MA micro automation LLP. The sales process aims to find a strategic partner to further support the growth path of the company. As a next step, several selected interested parties will be given the opportunity to conduct due diligence on the MA micro group. It is uncertain at this stage whether there will be a sale of the MA micro group.
CONTACT:
End of Inside Information
08-Sep-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | MAX Automation SE |
Steinhöft 11 | |
20459 Hamburg | |
Germany | |
Phone: | +4940808058270 |
Fax: | +4940808058299 |
E-mail: | investor.relations@maxautomation.com |
Internet: | www.maxautomation.com |
ISIN: | DE000A2DA588 |
WKN: | A2DA58 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1722341 |
End of Announcement | EQS News Service |
|
1722341 08-Sep-2023 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.